HM
HALO icon

HealthCor Management’s Halozyme HALO Stock Holding History

HealthCor Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-104,482
Closed -$4.2M – 67
2021
Q4 		$4.2M Sell
104,482
-389,020
-79% -$14.5M 0.23% 53
2021
Q3 		$20.1M Sell
493,502
-155,550
-24% -$6.5M 0.87% 32
2021
Q2 		$29.5M Sell
649,052
-96,553
-13% -$4.27M 1.18% 32
2021
Q1 		$31.1M Buy
+745,605
New +$34M 1.1% 33

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HealthCor Management's HALO Position: Q1 2022 in Review

HealthCor Management sold out of Halozyme (HALO) in Q1 2022, closing a stake of 104,482 shares — an estimated $4.2M sold.

HealthCor Management first reported a position in HALO in Q1 2021 and held it in 4 quarters. The position peaked at $31.1M in Q1 2021. 316 funds tracked by Wall St. Rank hold HALO as of Q1 2022.

  • HealthCor Management reported no remaining Halozyme position as of Q1 2022 after selling out during the quarter.
  • HealthCor Management sold 104,482 Halozyme shares in Q1 2022, an estimated $4.2M.
  • HealthCor Management first reported a position in Halozyme in Q1 2021 and held it in 4 quarters.
  • HealthCor Management's Halozyme position peaked at $31.1M in Q1 2021.
  • 316 funds tracked by Wall St. Rank held Halozyme as of Q1 2022.

Based on HealthCor Management's 13F filing for Q1 2022, filed 16 May 2022.